JonathanRSpornMD

Oncology • Hartford, CT

Professor, Medicine, University of Connecticut SOM

Join to view full profile

Dr. Sporn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Sporn's full profile

Already have an account?

Office
114 Woodland St
Hartford, CT 06105
Phone+1 860-714-4680
Is this information wrong?

Education & Training

Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1984 - 1986
UMass Chan Medical SchoolResidency, Internal Medicine, 1981 - 1984
SUNY Upstate Medical UniversityClass of 1981

Certifications & Licensure

CT State Medical License 1987 - 2022
VT State Medical License 1984 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

5 citations
A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer.
Michael Cecchini, Jeremy S. Kortmansky, Can Cui, Wei Wei, Jaykumar R. Thumar, Nataliya Volodymyrivna Uboha, Navid Hafez, Jill Lacy, Neal A. Fischbach, Kert D. Sabbath,...> ;Cancer. 2020 Dec 22
1 citations
Serious adverse events in African-American cancer patients with sickle cell trait and inherited haemoglobinopathies in a SEER-Medicare claims cohort.
Jessica R. Hoag, Biree Andemariam, Xiaoyan Wang, David I. Gregorio, Beth A. Jones, Jonathan R. Sporn, Andrew L. Salner, Helen Swede> ;British Journal of Cancer. 2019 Mar 20
Metastasis Squared: Colon Cancer Spread to the Preexisting Skeletal Metastasis of Thyroid Carcinoma
Shounak Majumder, Jonathan R. Sporn, Xuemei Li, Eric A Silverstein, George H Barrows> ;The American Journal of Gastroenterology. 2012 Jun 1
228 citations
An open-label trial of riluzole in patients with treatment-resistant major depression.
Carlos A. Zarate, Jennifer L. Payne, Jorge A. Quiroz, Jonathan R. Sporn, Kirk K. Denicoff, David A. Luckenbaugh, Dennis S. Charney, Husseini K. Manji> ;The American Journal of Psychiatry. 2004 Jan 1
38 citations
Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation
Nitya G. Chakraborty, Robert L. Stevens, Shikhar Mehrotra, Elizabeth Laska, Pamela Taxel, Jonathan R. Sporn, Peter Schauer, Peter C. Albertsen> ;Cancer Immunology, Immunotherapy. 2003 Jun 3
373 citations
Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.
Husseini K. Manji, Jorge A. Quiroz, Jonathan R. Sporn, Jennifer L. Payne, Kirk D. Denicoff, Neil A. Gray, Carlos A. Zarate, Dennis S. Charney> ;Biological Psychiatry. 2003 Apr 15
1 citations
Monoamine and neuropeptide-related function: prospects for novel therapeutics of depression.
Jonathan R. Sporn, Dennis S. Charney> ;Expert Review of Neurotherapeutics. 2002 Mar 1
7 citations
Reversible granulocytopenia in association with riluzole therapy
Will A North, A.M. Khan, Harold Yamase, Jonathan R. Sporn> ;The Annals of Pharmacotherapy. 2000 Mar 1
10 citations
Unusual presentation of a Merkel cell carcinoma.
Tanya G. Chiarelli, Jane M. Grant-Kels, Jonathan R. Sporn, William N. Rezuke, James D. Whalen> ;Journal of the American Academy of Dermatology. 2000 Feb 1
45 citations
Emergence of regulatory CD4+ T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell-based ...
Nitya G. Chakraborty, Li Li, Jonathan R. Sporn, Scott H. Kurtzman, M. T. Ergin, Bijay Mukherji> ;Journal of Immunology. 1999 May 1
13 citations
Practical recommendations for the management of adenocarcinoma of the pancreas.
Jonathan R. Sporn> ;Drugs. 1999 Jan 1
51 citations
Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanoma.
Nitya G. Chakraborty, Jonathan R. Sporn, Anne F. Tortora, Scott H. Kurtzman, Harold Yamase, M. T. Ergin, Bijay Mukherji> ;Cancer Immunology, Immunotherapy. 1998 Sep 1
15 citations
Treatment of advanced pancreatic adenocarcinoma with 5-FU, leucovorin, interferon-alpha-2b, and cisplatin.
Jonathan R. Sporn, Antonio C. Buzaid, Dennis Slater, Neil Cohen, Bernard R. Greenberg> ;American Journal of Clinical Oncology. 1997 Feb 1
122 citations
Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vaccine
Xueyou Hu, Nitya G. Chakraborty, Jonathan R. Sporn, Scott H. Kurtzman, M. T. Ergin, Bijay Mukherji> ;Cancer Research. 1996 Jun 1
11 citations
Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast cancer.
Scot C. Remick, Mary Chmura, Cheryl Bromberg, Jonathan R. Sporn, Barbara Healey, Jane Hilstro, Ronald C. DeConti, John Horton, John C. Ruckdeschel, Gregory R. Harper> ;American Journal of Clinical Oncology. 1996 Apr 1
251 citations
INDUCTION OF ANTIGEN-SPECIFIC CYTOLYTIC T CELLS IN SITU IN HUMAN MELANOMA BY IMMUNIZATION WITH SYNTHETIC PEPTIDE-PULSED AUTOLOGOUS ANTIGEN PRESENTING CELLS
Bijay Mukherji, Nitya G. Chakraborty, Seiji Yamasaki, Takashi Okino, Harold Yamase, Jonathan R. Sporn, S K Kurtzman, M. T. Ergin, J Ozols, J. L. Meehan> ;Proceedings of the National Academy of Sciences of the United States of America. 1995 Aug 15
17 citations
Case Report of Taxol Administration via Central Vein Producing a Recall Reaction at a Site of Prior Taxol Extravasation
J. L. Meehan, Jonathan R. Sporn> ;Journal of the National Cancer Institute. 1994 Aug 17
3 citations
Coagulation Abnormalities in Cancer Patients: Clinical Relevance
Jonathan R. Sporn, Frederick R. Rickles> ;Chest. 1994 Jun 1
28 citations
The role of flow cytometry in the diagnosis of lymphoma: a critical analysis
EE Morse, Harold Yamase, Bernard R. Greenberg, Jonathan R. Sporn, SA Harshaw, TR Kiraly, RA Ziemba, MA Fallon> ;Annals of Clinical and Laboratory Science. 1994 Jan 1
33 citations
Empirical chemotherapy for adenocarcinoma of unknown primary tumor site
Jonathan R. Sporn, Bernard R. Greenberg> ;Seminars in Oncology. 1993 Jun 1
4 citations
Adoptive immunotherapy with peripheral blood lymphocytes cocultured in vitro with autologous tumor cells and interleukin-2.
Jonathan R. Sporn, Michael T. Ergin, Gerald R. Robbins, Ritchard G. Cable, Herbert Silver, Bijay Mukherji> ;Cancer Immunology, Immunotherapy. 1993 May 1
1 citations
Acute adult T-cell leukemia/lymphoma presenting with florid cutaneous disease.
Stephanie A. Wright, Marti J. Rothe, Jonathan R. Sporn, Abby S. Van Voorhees, Jane M. Grant-Kels> ;International Journal of Dermatology. 1992 Aug 1
7 citations
Recovery from widespread bone marrow necrosis occurring after chemotherapy for adult acute monocytic leukemia.
Jonathan R. Sporn, Margaret A. Fallon> ;Medical and Pediatric Oncology. 1992 Jan 1
14 citations
Suppression of lymphokine-activated killer cell generation by tumor-infiltrating lymphocytes.
Nitya G. Chakraborty, Jonathan R. Sporn, Dominick R. Pasquale, M. T. Ergin, Bijay Mukherji> ;Clinical Immunology and Immunopathology. 1991 Jun 1
Tissue fragments passed after colonoscopic polypectomy.
Jonathan R. Sporn, Bernard R. Greenberg, Harold Yamase, G. Peter Bloom, James H. Foster> ;Gastrointestinal Endoscopy. 1991 Mar 1
Join now to see all